BACKGROUND: Fetal adaptations to high fat (HF) diet in utero (IU) that may predispose to Metabolic Syndrome (MetS) in adulthood include changes in fetal hepatic gene expression. Studies were performed to determine whether maternal exposure to HF diet at different stages during pregnancy had different effects on the fetus, including hepatic gene expression. METHODS: Female wild type mice were fed either a HF or breeding chow (C) for 2 wks prior to mating. The experimental groups were composed of embryonic day (e) 18.5 fetuses obtained from WT female mice that were fed HF (HF, 35.5% fat) or breeding chow (C, 9.5% fat) for 2 wk before mating until e9.5 of pregnancy (periconception-midpregnancy). At e9.5 dams were switched to the opposite diet (C-HF or HF-C). RESULTS: Exposure to HF diet throughout pregnancy reduced maternal weight gain compared to C diet (p < 0.02 HF vs. C). HF-C dams had significantly decreased adiponectin levels and litter size when compared to C-HF (p < 0.02 HF-C vs C-HF). Independent of the timing of exposure to HF, fetal weight and length were significantly decreased when compared to C diet (HF, C-HF and HF-C vs. C p < 0.02). HF diet during the second half of pregnancy increased expression of genes in the fetal liver associated with fetal growth (C-HF vs C p < 0.001), glucose production (C-HF vs C p < 0.04), oxidative stress and inflammation (C-HF vs C p < 0.01) compared to C diet. CONCLUSIONS: This model defines that there are critical periods during gestation in which the fetus is actively shaped by the environment. Early exposure to a HF diet determines litter size while exposure to HF during the second half of pregnancy leads to dysregulation of expression of key genes responsible for fetal growth, hepatic glucose production and oxidative stress. These findings underscore the importance of future studies designed to clarify how these critical periods may influence future risk of developing MetS later in life.
BACKGROUND: Fetal adaptations to high fat (HF) diet in utero (IU) that may predispose to Metabolic Syndrome (MetS) in adulthood include changes in fetal hepatic gene expression. Studies were performed to determine whether maternal exposure to HF diet at different stages during pregnancy had different effects on the fetus, including hepatic gene expression. METHODS: Female wild type mice were fed either a HF or breeding chow (C) for 2 wks prior to mating. The experimental groups were composed of embryonic day (e) 18.5 fetuses obtained from WT female mice that were fed HF (HF, 35.5% fat) or breeding chow (C, 9.5% fat) for 2 wk before mating until e9.5 of pregnancy (periconception-midpregnancy). At e9.5 dams were switched to the opposite diet (C-HF or HF-C). RESULTS: Exposure to HF diet throughout pregnancy reduced maternal weight gain compared to C diet (p < 0.02 HF vs. C). HF-C dams had significantly decreased adiponectin levels and litter size when compared to C-HF (p < 0.02 HF-C vs C-HF). Independent of the timing of exposure to HF, fetal weight and length were significantly decreased when compared to C diet (HF, C-HF and HF-C vs. C p < 0.02). HF diet during the second half of pregnancy increased expression of genes in the fetal liver associated with fetal growth (C-HF vs C p < 0.001), glucose production (C-HF vs C p < 0.04), oxidative stress and inflammation (C-HF vs C p < 0.01) compared to C diet. CONCLUSIONS: This model defines that there are critical periods during gestation in which the fetus is actively shaped by the environment. Early exposure to a HF diet determines litter size while exposure to HF during the second half of pregnancy leads to dysregulation of expression of key genes responsible for fetal growth, hepatic glucose production and oxidative stress. These findings underscore the importance of future studies designed to clarify how these critical periods may influence future risk of developing MetS later in life.
Authors: Emily Angiolini; Phillip M Coan; Ionel Sandovici; O H Iwajomo; Gerrard Peck; Graham J Burton; Colin P Sibley; Wolf Reik; Abigail L Fowden; Miguel Constância Journal: FASEB J Date: 2011-01-31 Impact factor: 5.191
Authors: Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington Journal: Diabetes Date: 2010-02-25 Impact factor: 9.461
Authors: Emily S Jungheim; Erica L Schoeller; Kerri L Marquard; Erica D Louden; Jean E Schaffer; Kelle H Moley Journal: Endocrinology Date: 2010-06-23 Impact factor: 4.736
Authors: Margaret J R Heerwagen; Melissa R Miller; Linda A Barbour; Jacob E Friedman Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-07-14 Impact factor: 3.619
Authors: Kirsten Hartil; Patricia M Vuguin; Michael Kruse; Esther Schmuel; Ariana Fiallo; Carlos Vargas; Matthew J Warner; Jorge L Durand; Linda A Jelicks; Maureen J Charron Journal: Pediatr Res Date: 2009-10 Impact factor: 3.756
Authors: Junlong Zhang; Fang Zhang; Xavier Didelot; Kimberley D Bruce; Felino R Cagampang; Manu Vatish; Mark Hanson; Hendrik Lehnert; Antonio Ceriello; Christopher D Byrne Journal: BMC Genomics Date: 2009-10-16 Impact factor: 3.969
Authors: Maureen J Charron; Lyda Williams; Yoshinori Seki; Xiu Quan Du; Bhagirath Chaurasia; Alan Saghatelian; Scott A Summers; Ellen B Katz; Patricia M Vuguin; Sandra E Reznik Journal: Diabetes Date: 2020-05-22 Impact factor: 9.461
Authors: Zeenat A Asghar; Alysha Thompson; Maggie Chi; Andrew Cusumano; Suzanne Scheaffer; Noor Al-Hammadi; Jessica L Saben; Kelle H Moley Journal: Sci Rep Date: 2016-04-29 Impact factor: 4.379